companydata.dkcompanydata.dk

ORIFARM GENERICS HOLDING A/S: Financial statements 2016

CVR: 27347223

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

ORIFARM GENERICS HOLDING A/S (CVR 27347223) has filed annual accounts for 2016. In 2016, the company reported a gross profit of EUR 1,010,000 and a net result of EUR 9,035,000 compared with DKK 5,160,000 the year before. That is a decrease of 82.1% compared with the year before. Equity in the 2016 report amounted to EUR 34,954,000. The solvency ratio was 52.9%. The company had 165 employees in the financial year.

Gross Profit
EUR 1,010,000
Profit/Loss
EUR 9,035,000
Equity
EUR 34,954,000
Total Assets
EUR 66,098,000
Employees
165

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-1M EUR9M EUR35M EUR165
2015-5.7M5.2M194.3M-
2014-8.2M4.1M15.3M-
2013-6.8M-150K11.5M-
2012-13.1M7.1M12M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ORIFARM GENERICS HOLDING A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2016

Birgitte Bøgh-Sørensen joins the board of ORIFARM GENERICS HOLDING A/SJul 4, 2016

As of July 4, 2016, Birgitte Bøgh-Sørensen has joined the board of directors of ORIFARM GENERICS HOLDING A/S.

Peter Arend William Burema leaves the board of ORIFARM GENERICS HOLDING A/SJul 4, 2016

As of July 4, 2016, Peter Arend William Burema has left the board of directors of ORIFARM GENERICS HOLDING A/S.

Claudio Albrecht leaves the board of ORIFARM GENERICS HOLDING A/SJul 4, 2016

As of July 4, 2016, Claudio Albrecht has left the board of directors of ORIFARM GENERICS HOLDING A/S.

ORIFARM GENERICS HOLDING A/S: The 2015 annual report is outJun 6, 2016

ORIFARM GENERICS HOLDING A/S has published its annual report for 2015. Gross profit came to DKK 5,654,000, and the net result was DKK 5,160,000.

Claus Christian Bayer leaves the board of ORIFARM GENERICS HOLDING A/SMay 31, 2016

As of May 31, 2016, Claus Christian Bayer has left the board of directors of ORIFARM GENERICS HOLDING A/S.

Rolf Eckersberg leaves the board of ORIFARM GENERICS HOLDING A/SMay 31, 2016

As of May 31, 2016, Rolf Eckersberg has left the board of directors of ORIFARM GENERICS HOLDING A/S.

About ORIFARM GENERICS HOLDING A/S

ORIFARM GENERICS HOLDING A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named COPYFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Birgitte Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 0 employees (2016). In 2025, the company reported revenue of DKK 459,463,000 and a net result of DKK 273,125,000 compared with DKK 89,363,000 the year before. Equity in the 2025 report amounted to DKK 2,399,752,000.

Source: annual report 2025, Danish Business Authority